Logo-aim
Arch Iran Med. 2025;28(1): 29-39.
doi: 10.34172/aim.33366
  Abstract View: 195
  PDF Download: 168

Original Article

Gastroenteropancreatic Neuroendocrine Tumors: Does Tumor Location Affect Prognosis?

Mehmet Sait Ozsoy 1 ORCID logo, Cem Ilgin Erol 2 ORCID logo, Muhammet Ali Aydemir 1* ORCID logo, Hakan Baysal 1 ORCID logo, Fatih Buyuker 1 ORCID logo, Hatice Seneldir 3 ORCID logo, Ozgur Ekinci 1 ORCID logo, Tunc Eren 1 ORCID logo, Orhan Alimoglu 1 ORCID logo

1 Department of General Surgery, Faculty of Medicine, Istanbul Medeniyet University, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey
2 Department of General Surgery, Erzurum City Hospital, Erzurum, Turkey
3 Department of Pathology, Faculty of Medicine, Istanbul Medeniyet University, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey
*Corresponding Author: Muhammet Ali Aydemir, Email: maliaydemir1990@gmail.com

Abstract

Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare entities. Generally, they can be localized anywhere in the gastrointestinal or hepatobiliary tract. The purpose of our study is to evaluate the effect of tumor location on prognosis in patients with GEP-NET undergoing surgery. Our secondary objective is to examine other factors affecting the prognosis of patients with GEP-NET.

Methods: We retrospectively analyzed data from 30 patients with GEP-NET who underwent surgery in the General Surgery Clinic between 2012 and 2022. The gNET group (n=18) included tumors located in the gastrointestinal tract, while the pNET group (n=12) included tumors located in the hepatopancreatobiliary system. Surgical, laboratory, radiological, and pathological findings of the patients, as well as follow-up outcomes were recorded and statistically analyzed.

Results: In subgroup comparison, tumor size was found to be larger in the pNET group (P=0.002). The statistical analysis of recurrence (16.7% versus 33.3%) and mortality rates (16.7% versus 41.7%) between the subgroups (P=0.329 and P=0.210, respectively) did not reveal a significant difference. When all patients were evaluated, it was observed that advanced age, presence of carcinoma diagnosis, higher tumor grade, advanced TNM stage, larger tumor size, presence of lymphovascular or perineural invasion, elevated mitotic index, higher Ki-67 index, and having received adjuvant therapy increased the rates of recurrence and mortality.

Conclusion: There was no statistically significant difference in survival outcomes between the GEP-NET groups located in the gastrointestinal tract and the hepatopancreatobiliary system.



Cite this article as: Ozsoy MS, Erol CI, Aydemir MA, Baysal H, Buyuker F, Seneldir H, et al. Gastroenteropancreatic neuroendocrine tumors: does tumor location affect prognosis?. Arch Iran Med. 2025;28(1):29-39. doi: 10.34172/aim.33366
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 166

Your browser does not support the canvas element.


PDF Download: 168

Your browser does not support the canvas element.

Submitted: 27 Oct 2024
Accepted: 11 Nov 2024
ePublished: 01 Jan 2025
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)